Oral pantoprazole for erosive esophagitis: a placebo-controlled, randomized clinical trial. Pantoprazole US GERD Study Group.
about
Medical treatments in the short term management of reflux oesophagitisMedical treatments in the short term management of reflux oesophagitisAn update on the use of pantoprazole as a treatment for gastroesophageal reflux diseaseMeta-analysis: the effects of placebo treatment on gastro-oesophageal reflux disease.A systematic review of symptomatic outcomes used in oesophagitis drug therapy trials.Systematic review: proton-pump inhibitor failure in gastro-oesophageal reflux disease--where next?Community-acquired pneumonia and acid-suppressive drugs: position statementAssociation between proton pump inhibitors and respiratory infections: a systematic review and meta-analysis of clinical trials.Pantoprazole: a proton pump inhibitor with oral and intravenous formulations.Prevalence of complicated gastroesophageal reflux disease and Barrett's esophagus among racial groups in a multi-center consortium.Guidelines for the diagnosis and management of gastroesophageal reflux disease: an evidence-based consensus.A clinical guide to using intravenous proton-pump inhibitors in reflux and peptic ulcers.Response of regurgitation to proton pump inhibitor therapy in clinical trials of gastroesophageal reflux disease.Current Trends in the Management of Gastroesophageal Reflux Disease.PPI therapy is equally effective in well-defined non-erosive reflux disease and in reflux esophagitis: a meta-analysis.Comparison of the efficacy and safety of pantoprazole magnesium and pantoprazole sodium in the treatment of gastro-oesophageal reflux disease: a randomized, double-blind, controlled, multicentre trial.Pantoprazole provides rapid and sustained symptomatic relief in patients treated for erosive oesophagitis.Comparison of the efficacy of pantoprazole vs. nizatidine in the treatment of erosive oesophagitis: a randomized, active-controlled, double-blind study.Head-to-head comparison of H2-receptor antagonists and proton pump inhibitors in the treatment of erosive esophagitis: a meta-analysis.Comparative effectiveness and acceptability of the FDA-licensed proton pump inhibitors for erosive esophagitis: A PRISMA-compliant network meta-analysis.Long-term management of gastroesophageal reflux disease with pantoprazole.Clinical results from a randomized, double-blind, dose-ranging study of pantoprazole in children aged 1 through 5 years with symptomatic histologic or erosive esophagitis.Influence of pantoprazole on oesophageal motility, and bile and acid reflux in patients with oesophagitis.Dose-dependent control of intragastric pH by pantoprazole, 10, 20 or 40 mg, in healthy volunteers.Pantoprazole maintenance therapy prevents relapse of erosive oesophagitis.Prevention of erosive oesophagitis relapse with pantoprazole.Comparison of risk factors and clinical responses to proton pump inhibitors in patients with erosive oesophagitis and non-erosive reflux disease.Development of a refractory gastro-oesophageal reflux score using an administrative claims database.Nighttime heartburn in patients with gastroesophageal reflux disease under routine care.Cost-effectiveness model of endoscopic biopsy for eosinophilic esophagitis in patients with refractory GERD.Meta-analysis of the efficacy and safety of pantoprazole in the treatment and symptom relief of patients with gastroesophageal reflux disease - PAN-STAR.Symptom Resolution Does Not Predict Healing of Erosive Oesophagitis in Chinese
P2860
Q24234225-B00500D5-2A51-46AA-B5E5-0BC65EBE614DQ24245220-F5B9C4A2-4613-4B01-9101-9AAC7979AF05Q34194502-6D8DA431-6B0E-4EAA-8E0A-975D74B7FCB7Q35147233-30757AF2-98C9-4C4D-83BB-8464F1AE4C5FQ35745058-46B743D5-0533-4F0B-9C53-8EFF5914842FQ36191254-2DF829D7-742B-4312-986F-B7DD26167976Q36398145-DE3B37FE-F461-47D7-ABB8-BF0AE4E13EBDQ37279832-25AFD822-66B7-46FC-AB9E-36F0D4F9B86AQ37345977-F94D3D38-99E5-47E0-A991-75D3A5C8E5DCQ37376770-8B1646D8-2DB2-4E9B-AAC9-42325E882D3DQ37762466-91A8D108-68B2-4118-B4B5-924744CED0F5Q37823319-0CF00AFC-D333-4B5D-AFA5-2AD8C7B78C5CQ37871345-B327E796-5C95-4281-811F-2E01010CB71CQ38692672-56497194-CDF2-45EA-BDF0-7F549A5B480CQ39252347-D46B0E3C-85FE-4A84-8559-280E48120BDCQ39261341-A335D7A6-8380-45B7-84B9-478657BE0296Q39373552-ED51DD15-89EA-41BF-8B33-8DBE16AED7C7Q39400698-D8ACD778-6120-4EC9-AA19-1C617D122748Q41560226-F11B98CC-CE5B-40A7-A238-ACA2AE571BB1Q42283418-FC16BBB6-B1A2-4C91-934F-6FAB1AF056B3Q42429093-EA95E39E-56C7-46D4-9437-BA82C422B094Q43045037-F35E1750-6CD5-493C-B416-204490860A6DQ43734565-0A493D21-4E0B-401A-AC28-22125F69288EQ43944832-531FCAB7-C6C8-4F56-8BB3-6975EA88D498Q44256494-6E6CDF27-F75D-499B-9816-CE58DCB5D6FBQ45038168-C50EDE77-6A4D-47B5-A0AE-2AC8D47EEBE1Q46037784-49321A62-3BCE-4AA5-AF03-7B3C00B31B68Q51444133-627E9BD5-7F9B-441C-B82B-B54A316301EBQ52919618-F9031554-089A-4A6A-876E-20549D2F8B04Q53043334-73916EE2-FFD4-45CD-87E7-C5A012A4750BQ53830142-79D7F57F-F655-4466-A713-E8A03160E8E2Q58376483-3F0CC819-BCD3-4B73-87D3-23507E559532
P2860
Oral pantoprazole for erosive esophagitis: a placebo-controlled, randomized clinical trial. Pantoprazole US GERD Study Group.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Oral pantoprazole for erosive ...... toprazole US GERD Study Group.
@en
Oral pantoprazole for erosive ...... toprazole US GERD Study Group.
@nl
type
label
Oral pantoprazole for erosive ...... toprazole US GERD Study Group.
@en
Oral pantoprazole for erosive ...... toprazole US GERD Study Group.
@nl
prefLabel
Oral pantoprazole for erosive ...... toprazole US GERD Study Group.
@en
Oral pantoprazole for erosive ...... toprazole US GERD Study Group.
@nl
P1476
Oral pantoprazole for erosive ...... toprazole US GERD Study Group.
@en
P2093
J E Richter
W Bochenek
P304
P356
10.1111/J.1572-0241.2000.03254.X
P407
P577
2000-11-01T00:00:00Z